Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 10, 2025
Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantationShun-Ichi Kimura, Shunto Kawamura, Takashi Toya, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 14, 2026
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Kazuki Yoshimura, Hideki Nakasone, et al.
International Journal of Hematology|May 20, 2025
Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in JapanTsuneaki Hirakawa, Hiromasa Yabe, Masayuki Hino, et al.
Transplantation and Cellular Therapy|March 19, 2025
Clinical effects of granulocyte colony-stimulating factor administration and the timing of its initiation on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromeTakaaki Konuma, Machiko Fujioka, Kyoko Fuse, et al.
Annals of Hematology|November 19, 2024
Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationShohei Mizuno, Hiroki Hosoi, Akiyoshi Takami, et al.
International Journal of Hematology|March 27, 2024
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemiaKensuke Usuki, Toshihiro Miyamoto, Takuji Yamauchi, et al.
British Journal of Haematology|April 6, 2026
Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide studyHidehiro Itonaga, Yasushi Miyazaki, Noriaki Tachi, et al.
Transplantation and Cellular Therapy|April 13, 2026
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemiaYasuyuki Arai, Marie Ohbiki, Mio Kurata, et al.
American Journal of Hematology|September 5, 2025
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic AnemiaYoshitaka Zaimoku, Hirohito Yamazaki, Minoru Kanaya, et al.
American Journal of Hematology|March 2, 2026
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid LeukemiaShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Pageof 13